Testing The Addition Of The Chemotherapy Drug Lomustine (Gleostine) To The Usual Treatment (Temozolomide And Radiation Therapy) For Newly Diagnosed Mgmt Methylated Glioblastoma
Posted Date: Aug 28, 2025
- Investigator: Lalanthica Yogendran
- Type of Study: Drug
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma.
Criteria:
Null
Keywords:
Brain Tumor
For More Information:
Mary Horn
NULL
cancer@uchealth.com